Alkem Laboratories posts robust quarter
Alkem Laboratories reported its results for the quarter ended September 30, 2017 during market hours on Friday.
Total sales for this quarter, Q2FY18, came in at Rs. 1,864.9 crore. This represents a 43.99 per cent sequential increase and 13.83 per cent YoY increase.
Operating profit (EBIT) for the recently concluded quarter amounted to Rs. 460.3 crore and the EBIT margin stood at 24.68 per cent.
In terms of the bottom-line, the company reported a PAT figure of Rs. 327.4 crore which represents a sequential QoQ increase of 413.97 per cent and a YoY increase of 13.64 per cent.
The company's stock which opened for trading at Rs. 1937.55 has touched a high/low of Rs.1977/Rs.1910.25 and on 1457 hours the stock is quoting at Rs.1931.05